ICD-10 Coding for Cervical Dysplasia(N87.0, N87.0B, N87.0C)
Comprehensive guide to ICD-10 coding for cervical dysplasia, including N87 and R87 code ranges, documentation requirements, and common pitfalls.
Complete code families applicable to Cervical Dysplasia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| N87.0 | Mild cervical dysplasia | Use when biopsy confirms CIN1. |
|
| N87.1 | Moderate cervical dysplasia | Use when biopsy confirms CIN2. |
|
| R87.612 | Low-grade squamous intraepithelial lesion on cytology | Use for cytology findings without biopsy. |
|
| R87.613 | High-grade squamous intraepithelial lesion on cytology | Use for cytology findings without biopsy. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutCervical Dysplasia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Cervical Dysplasia.
Coding based on cytology without biopsy confirmation.
Impact
Clinical: Misrepresentation of disease severity., Regulatory: Potential audit failures., Financial: Incorrect billing and reimbursement.
Mitigation
Verify biopsy results before coding., Educate staff on coding guidelines.
Using N87.0 for LSIL on Pap without biopsy.
Impact
Reimbursement: Incorrect DRG assignment., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data.
Mitigation
Use R87.612 instead.
Histology vs. Cytology Coding
Impact
Risk of coding cytology findings as histology-confirmed dysplasia.
Mitigation
Implement double-check system for biopsy confirmation.